Mohs surgery

Olansky Dermatology & Aesthetics welcomes physician assistant, expands hours

Retrieved on: 
Tuesday, April 9, 2024
Psoriasis, Skin cancer, Patient, Mohs surgery, Aesthetics, Quality of life, Suite, Dermatology, Acne, Family

ATLANTA, April 09, 2024 (GLOBE NEWSWIRE) -- Olansky Dermatology & Aesthetics –Georgia’s top-rated dermatology practice– welcomes physician assistant Kathryn “Katie” Shea to its Buckhead location.

Key Points: 
  • ATLANTA, April 09, 2024 (GLOBE NEWSWIRE) -- Olansky Dermatology & Aesthetics –Georgia’s top-rated dermatology practice– welcomes physician assistant Kathryn “Katie” Shea to its Buckhead location.
  • This addition to the practice’s acclaimed staff allows Olansky Dermatology & Aesthetics the ability to offer new, expanded hours at its Buckhead location, a first for Atlanta area dermatology.
  • She has extensive experience in dermatology and urgent care medicine, and she is a member of the Georgia Association of Physician Assistants, American Academy of Physician Assistants, and Georgia Dermatology Physician Assistants.
  • “We strive to offer our patients the best providers possible,” says Dr. Jodi Ganz, physician partner at Olansky Dermatology & Aesthetics, “By growing our staff, it allows us to better meet patients where they are and provide additional hours for better flexibility.”
    Olansky Dermatology & Aesthetics is your dermatology solution.

Common Skin Cancer, Like Christie Brinkley’s, Can Often Be Cured Without Surgery

Retrieved on: 
Thursday, March 14, 2024
Skin, Skin cancer, Patient, SRT, Mohs surgery, Dermatology, Cancer, Insurance, Basal-cell carcinoma, Carcinoma, Patent, Pain, Medicare, Marketing, FDA, Food, Medical imaging

Basal cell carcinoma, which Brinkley had, and squamous cell carcinoma are forms of nonmelanoma skin cancer, the most common type of cancer in the United States.

Key Points: 
  • Basal cell carcinoma, which Brinkley had, and squamous cell carcinoma are forms of nonmelanoma skin cancer, the most common type of cancer in the United States.
  • Brinkley had Mohs surgery, the traditional treatment that dates back to the 1930s,” says dermatologist and surgeon Dr. Janine Hopkins of Hopkins Dermatology, Monroe, Louisiana and Southlake, Texas.
  • The treatment is administered over the course of 15-minute sessions, with no cutting, pain, surgical scarring or need for reconstructive surgery.
  • SkinCure Oncology recently announced receipt of a U.S. patent for a new image-guided technology that will be the fourth generation of SRT.

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting

Retrieved on: 
Wednesday, March 13, 2024
Deal, Keloid, SRT, Dermatology, Mohs surgery, BOCA, Vision, Patent, AAD, FDA, Medical imaging

BOCA RATON, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the successful launch of its new “Fair Deal Agreement” for the SRT-100 Vision™ (IG-SRT) at the AAD 2024 Annual Meeting, held March 8-12 in San Diego. This meeting is the largest gathering of dermatologists in the U.S., hosting more than 10,000 medical personnel at this year’s event.

Key Points: 
  • This meeting is the largest gathering of dermatologists in the U.S., hosting more than 10,000 medical personnel at this year’s event.
  • Sensus manufactures and sells the only proven, FDA-cleared IG-SRT system and holds a patent for SRT combined with ultrasound, which is deeper and more effective.
  • “The AAD Annual Meeting was the ideal forum to launch our new Fair Deal Agreement program, and the response among conference attendees exceeded our most optimistic expectations.
  • This technology is ideal for better managing dermatology clinical practice, and is a Sensus Healthcare exclusive.

Medicare Coverage Is Threatened for the 134,000 North Carolinians Likely to Get Skin Cancer this Year

Retrieved on: 
Tuesday, April 2, 2024
Dermatology, DART, Skin cancer, Federation, Diabetes, Patient, Research, Mohs surgery, Policy, Cancer, Insurance, Judgement, Blue Cross, Blue Shield, Carcinoma, Radiation, Medicare, FDA, Pain, Hearing, Medical imaging

Palmetto GBA, a subsidiary of Blue Cross and Blue Shield of South Carolina, is authorized by the federal government to regulate Medicare in North Carolina and six other states.

Key Points: 
  • Palmetto GBA, a subsidiary of Blue Cross and Blue Shield of South Carolina, is authorized by the federal government to regulate Medicare in North Carolina and six other states.
  • Palmetto is moving quickly to cancel coverage, which has been in effect nearly 10 years.
  • Medicare and private insurers should provide coverage for Image-Guided SRT whenever it's deemed the most suitable therapy by patients and their healthcare providers.
  • Consumers who care about keeping their insurance coverage for the nonsurgical treatment should write to the panel by May 11, at [email protected] .

Medicare Coverage Is Threatened for the 96,000 Tennesseans Likely to Get Skin Cancer this Year

Retrieved on: 
Tuesday, April 2, 2024
Dermatology, DART, Skin cancer, Federation, Diabetes, Patient, Research, Mohs surgery, Policy, Cancer, Insurance, Judgement, Blue Cross, Carcinoma, Blue Shield, Radiation, Medicare, FDA, Pain, Hearing, Medical imaging

Palmetto is moving quickly to cancel coverage, which has been in effect nearly 10 years.

Key Points: 
  • Palmetto is moving quickly to cancel coverage, which has been in effect nearly 10 years.
  • That would leave coverage only for procedures at radiation therapy cancer centers or for Mohs surgery in most cases, although Mohs surgeons are relatively few in number and are rarely found in rural communities.
  • Medicare and private insurers need to ensure coverage for Image-Guided SRT whenever it's considered the most appropriate treatment by patients and their medical teams.
  • Consumers who care about keeping their insurance coverage for the nonsurgical treatment should write to the panel by May 11, at [email protected] .

Quthero Welcomes Dr. Omar Ibrahimi as Chief Medical Director

Retrieved on: 
Tuesday, April 2, 2024
Mohs surgery, Regeneration, Trust, Bruise, Patient, Harvard University, American Academy, Red, Laser, Doctor of Philosophy, MD, American College, Regenerative medicine, Society, Skin, Scar, Physician

TORONTO, April 2, 2024 /PRNewswire/ -- Quthero, a pioneering biotech company renowned for its unique Q-peptide platform technology, welcomes Omar Ibrahimi, MD, PhD, a world-renowned dermatologist, to the Quthero team as their Chief Medical Director.

Key Points: 
  • TORONTO, April 2, 2024 /PRNewswire/ -- Quthero, a pioneering biotech company renowned for its unique Q-peptide platform technology, welcomes Omar Ibrahimi, MD, PhD, a world-renowned dermatologist, to the Quthero team as their Chief Medical Director.
  • Quthero proudly announces that renowned dermatologist, Dr. Omar Ibrahimi, joins the team as Chief Medical Director.
  • Dr. Ibrahimi, a Harvard-trained, board-certified dermatologist, is the founder and medical director of the Connecticut Skin Institute with over 20 years of experience.
  • "It is a privilege and a great honor to have Dr. Ibrahimi join Quthero to lead the launch of Quthero's post-procedure products as a Chief Medical Director.

SkinCure Oncology Unveils New Skin Cancer Treatment Technology at American Academy of Dermatology Annual Meeting in San Diego March 8-12 Booth 3555

Retrieved on: 
Thursday, March 7, 2024
Mohs surgery, Cancer, Carcinoma, SRT, Research, Pathology, FDA, Ageing, Food, RCM, Dermatology, Bed, Physiology, Epidermis, Vision, AAD, NMSC, Skin cancer, PAI, Patent, Patient, Tanning, United, American Academy, Medical imaging

GentleView™ is a laser-based imaging device being developed to offer hybrid reflective confocal microscopy and photoacoustic imaging.

Key Points: 
  • GentleView™ is a laser-based imaging device being developed to offer hybrid reflective confocal microscopy and photoacoustic imaging.
  • Reflective confocal microscopy, or RCM, will provide high resolution imaging of the epidermis, to a depth of 200 microns, for cellular level visualization of skin cancer lesions.
  • “SkinCure Oncology,” Brandt continued, “is helping dermatologists nationwide implement the GentleCure Experience – an advanced, noninvasive treatment for NMSC.
  • “Our new devices, subject to FDA Clearance,” Brandt said, “will offer cutting-edge technology in line with SkinCure Oncology’s vision for the future of dermatology.

SkinCure Oncology Unveils New Skin Cancer Treatment Technology at American Academy of Dermatology Annual Meeting in San Diego March 8-12 Booth 3555

Retrieved on: 
Thursday, March 7, 2024
Mohs surgery, Cancer, Carcinoma, SRT, Research, Pathology, FDA, Ageing, Food, RCM, Dermatology, Bed, Physiology, Epidermis, Vision, AAD, NMSC, Skin cancer, PAI, Patent, Patient, Tanning, American Academy, Medical imaging

Reflective confocal microscopy, or RCM, will provide high resolution imaging of the epidermis, to a depth of 200 microns, for cellular level visualization of skin cancer lesions.

Key Points: 
  • Reflective confocal microscopy, or RCM, will provide high resolution imaging of the epidermis, to a depth of 200 microns, for cellular level visualization of skin cancer lesions.
  • Brandt noted, "Mohs micrographic surgery has been the gold standard of care for the treatment of nonmelanoma skin cancer (NMSC) for more than 50 years.
  • "SkinCure Oncology," Brandt continued, "is helping dermatologists nationwide implement the GentleCure Experience – an advanced, noninvasive treatment for NMSC.
  • The new devices will feature technology for which SkinCure Oncology was recently awarded U.S. patent coverage.

Medical Journal: Image-Guided Superficial Radiation Therapy Is Superior to Superficial Radiation Therapy Without Guidance

Retrieved on: 
Tuesday, February 20, 2024
Mohs surgery, Skin cancer, Freedom, Recurrence, Carcinoma, Toxicity, SRT, American Academy of Dermatology, Research, ASTRO, FDA, Skin, BCC, Radiation, SCC, NMSC, Society, Silverman, Patient, Histology, Photon, Radiation therapy, Cancer, American Academy, Medical imaging

BURR RIDGE, Ill., Feb. 20, 2024 /PRNewswire/ -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT) for the treatment of nonmelanoma skin cancer, presented to dermatology patients as the GentleCure™ experience, announced the publication of research, "Image guidance improves freedom from recurrence in superficial radiation therapy for non-melanoma skin cancer," in Advances in Radiation Oncology, a peer-reviewed journal from the American Society for Radiation Oncology (ASTRO).

Key Points: 
  • It shows definitively that the new technology is superior, and represents a seminal moment in the care of skin cancer patients using radiation.
  • This study is the first to rigorously compare SRT to IGSRT, and it covers all the data that exists on IGSRT.
  • Superficial radiation therapy was developed over 100 years ago ( here ) and was the standard therapy for nonmelanoma skin cancer until Mohs micrographic surgery emerged in the 1930's ( here ).
  • IGSRT and the GentleCure experience will be showcased at the upcoming American Academy of Dermatology annual meeting in San Diego, at booth 3555.

Olansky Dermatology & Aesthetics welcomes Dr. Ajdin Kobic to acclaimed roster

Retrieved on: 
Wednesday, February 14, 2024
Mohs surgery, Skin cancer, Psoriasis, Suite, Blepharoplasty, Dermatology, Society, Emory University, Mayo Clinic, Clinical professor, American College, Patient, Family, Plastic surgery, Laser, Aesthetics, American Academy, Veterinary medicine

ATLANTA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Olansky Dermatology & Aesthetics –Georgia’s top-rated dermatology practice– welcomes Dr. Ajdin Kobic, a board-certified dermatologist and fellowship-trained Mohs micrographic and reconstructive surgeon.

Key Points: 
  • ATLANTA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Olansky Dermatology & Aesthetics –Georgia’s top-rated dermatology practice– welcomes Dr. Ajdin Kobic, a board-certified dermatologist and fellowship-trained Mohs micrographic and reconstructive surgeon.
  • With the addition of Dr. Kobic to the practice’s acclaimed team, patients can continue to choose Olansky Dermatology & Aesthetics with confidence.
  • “Patients looking to rejuvenate and revitalize their appearance have an incredible asset in Dr. Kobic,” says Dr. Jodi Ganz, physician partner at Olansky Dermatology & Aesthetics.
  • To schedule an appointment with Dr. Kobic at Olansky Dermatology & Aesthetics, visit OlanskyDermatology.com/Schedule or call: 404-355-5484.